• Expanded Table 1 110 (17) 66 (10) 30 (5) 15 (2) 2 (1)
Risk factors for HCV infection, n/total (%)
Illicit drug use (27) 41 (6) 106 (17) 8 (1) 98 (15) 51 (8) 19 (3) 7 ( (72) 166 (26) 63 (10) 42 (7) 36 (6) 27 (4) 7 (1) Disease status, a n/total (%)
Complete remission
Partial remission
Stable disease
Progressive disease 223 (35) 14 (2) 96 (15) 295 ( 26 (65) 13 (33) 1 (2) Mean baseline body mass index (kg/m 2 ) ± SD 27.4 ± 6.1
Basal HCV viral load >600,000 IU/mL 298 (69)
Mean baseline serum cholesterol (mg/dL) ± SD 167.1 ± 40.5
Mean baseline serum triglycerides (mg/dL) ± SD 150.5 ± 98.9
Coinfection, a n (%) HIV 197 (39) 7 (1) 10 (2 Acute myeloid leukemia 0/9 (0) 2/22 (9) Acute lymphocytic leukemia 0/9 (0) 1/22 (5) Chronic myeloid leukemia 1/9 (11) 0/22 (0) Chronic lymphocytic leukemia 0/9 (0) 2/22 (9) Hodgkin lymphoma 0/9 (0) 1/22 (5) Non-Hodgkin's lymphoma 7/9 (78) 13/22 (59) Prothrombin time (s) 13.5 ± 0.7 13.8 ± 0.6 .67
International normalized ratio 1.3 ± 0.2 1.2 ± 0.1 .95
Alkaline phosphatase (IU/L) 97.3 ± 7.8 120.3 ± 11.1 .41
Total bilirubin (mg/dL) 0.6 ± 0.1 0.7 ± 0.1 .69
Albumin (g/dL) 4.1 ± 0.1 3.8 ± 0.1 .14 Hemoglobin (g/dL) 12.8 ± 0.4 13.4 ± 0. 
